House Bill No. 7179, also known as Public Act No. 25-171, introduces significant changes to the regulation of pharmaceutical marketing and the dispensing of veterinary drugs. The bill requires pharmaceutical manufacturers with representatives to register annually as pharmaceutical marketing firms, with a registration fee of $150 and a late fee of $100 for late renewals. These firms must provide a list of their representatives to the Department of Public Health, which will maintain a public list of representatives while protecting their home addresses. Additionally, the bill allows licensed veterinarians to authorize individuals to dispense prescription veterinary drugs under their supervision and updates regulations for the sale of nonlegend drugs, permitting their sale in vending machines operated by permitted businesses, subject to strict maintenance and labeling requirements.

The bill also includes amendments related to the distribution of nonlegend naloxone, allowing individuals to distribute it through secure boxes without needing a permit, provided the boxes meet specific criteria. It modifies the permit application process for selling nonlegend drugs, allowing fee waivers for those distributing without compensation. The bill clarifies definitions and requirements for secure boxes, mandates proper storage and handling of opioid antagonists, and allows certified practitioners and pharmacists to operate vending machines for naloxone distribution. These machines must display information on overdose signs, usage instructions, and treatment services. Additionally, the bill protects practitioners and pharmacists from liability related to the administration of these medications and grants the Commissioner of Consumer Protection the authority to adopt necessary regulations.

Statutes affected:
Public Act No. 25-171: 20-623, 20-624